Systems Biology In CNS: Mixed Results For IRLAB's Dyskinesia Candidate
A novel systems biology/network pharmacology approach to drug discovery in Parkinson’s disease is encouraging despite puzzling divergence in efficacy measures.
A novel systems biology/network pharmacology approach to drug discovery in Parkinson’s disease is encouraging despite puzzling divergence in efficacy measures.